SCHEMBL3028808

SCHEMBL3028808

CCOC(Cl)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9034361 0.77
SCHEMBL3229118 0.77
SCHEMBL21633905 0.77
SCHEMBL559406 0.76 ALOX15 (0.46)
SCHEMBL596654 0.75 ALDH1A1 (0.43)
SCHEMBL30096756 0.75 ALDH1A1 (0.43)
SCHEMBL13485048 0.74 ALOX15 (0.43)
Hydrochloric Acid SCHEMBL6028543 0.73 ALDH1A1 (0.42)
SCHEMBL27789246 0.73
SCHEMBL2078307 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109705334-A A kind of quinacridone derivative and its preparation method and application 沈阳化工研究院有限公司 2019-05-03 CN disclosed
US-20100210864-A1 PROCESS FOR THE PREPARATION OF N-ARYLMORPHOLINONES DORSCH DIETER 2010-08-19 US disclosed
US-7687624-B2 Process for the production of N-arylmorpholinones MERCK PATENT GMBH (DE) 2010-03-30 US disclosed
EP-1654240-B1 METHOD FOR PRODUCTION OF N-ARYL MORPHOLINONES MERCK PATENT GMBH (DE) 2006-11-02 EP disclosed
US-20060217550-A1 One pot process; cyclization; 4-(4-nitrophenyl)-3-oxomorpholine; Factor Xa inhibitors; , myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty and claudicatio intermittens MERCK PATENT GMBH (DE) 2006-09-28 US disclosed
EP-1654240-A1 METHOD FOR PRODUCTION OF N-ARYL MORPHOLINONES MERCK PATENT GmbH (DE) 2006-05-10 EP disclosed
WO-2005016899-A1 METHOD FOR PRODUCTION OF N-ARYL MORPHOLINONES MERCK PATENT GMBH (DE) 2005-02-24 WO disclosed